Mary "Roselin" R. Nittala, DrPH
Assistant Professor
Department:
SOM-Radiation/Oncology
Email:
mnittala@umc.edu
Work Phone:
(601) 984-2562
Biography
Roselin Nittala, DrPH, FRSPH, is an Assistant Professor in the Radiation Oncology department. Her research interests and focus are analyzing racial disparities in the survival outcomes of cancer (head and neck, cervix, prostate, breast, lung) and identifying the treatment strategies to minimize the racial bias effect on health care outcomes, with a focus on cancer. Her work has led to significant insights into the impact of race on cancer survival rates and has proposed effective strategies to address these disparities.
Dr. Nittala’s journey in academia is a testament to her unwavering dedication. She earned a Doctor of Public Health (DrPH) from Jackson State University in 2019. She immediately embarked on her postdoctoral fellowship at the University of Mississippi Medical Center (UMMC) Department of Radiation Oncology. Her commitment to her field is evident in her 26 peer-reviewed cancer research articles and 30 peer-reviewed cancer research abstracts, which she has presented at National and International scientific meetings. Her research has significantly contributed to understanding racial disparities in cancer outcomes, shaping the discourse and strategies in the field.
Dr. Nittala’s extensive research has received many local, National, and International recognitions, and left a lasting impression. She became a Royal Society of Public Health Fellow in 2021, and her work has been honored with prestigious local awards such as the UMMC GWIMS Trainee Recognition Award 2021, the UMMC SGSHS Honors Day-The Postdoctoral Fellow Award 2022, and The Pillars- Beacon Award Honorable Mention 2024.
Dr. Nittala is an active member of many National and local professional societies. She is the chair of the Department of Radiation Oncology Research Council, leading discussions and initiatives to advance cancer research. During her postdoctoral training, she served as a UMMC GWIMS trainee representative and an advisory committee member for the UMMC SGSHS Office of Postdoctoral Studies, providing valuable insights and guidance. She serves on the UMMC GWIMS Executive Board as a President, implementing and coordinating an inclusive and supportive climate with unique opportunities for women faculty and learners to network, interact, and collaborate through UMMC GWIMS leadership events, connect share activities, and award ceremonies.
Dr. Nittala’s passion for mentoring is not just a part of her professional life, but a cornerstone of it. She finds great joy in guiding and supporting medical students in their pursuit of individual cancer research. Her commitment to their development is a testament to her dedication. She hopes to continue developing projects to improve access and quality of care for all cancer patients. When she is not in her cancer research element, she can be found in the gym working out or at a studio choreographing.
Education
| The University of Mississippi Medical Center, PostDoctoral Fellowship, Radiation Oncology | 2022 |
| Jackson State University, Doctor of Public Health, Epidemiology & Biostatistics | 2019 |
| Jackson State University, MS, Chemistry | 2008 |
Specialty Certification Licensure
| Certification, NIH/NCI GMap Region 2 targeted training workshop on Cancer Health Disparities, Moffitt Cancer Center | 11/2020 - Present |
| Certification, NIH Clinical Research IPPCR, National Institutes of Health- Office of Clinical Research | 07/2021 - Present |
| Certification, Clinical Research Education for the Workforce (CREW) Program, The University of Mississippi Medical Center | 05/2022 - Present |
| Certification, UMMC Diversity and Inclusion Champion & Professional Development Certificate Program MASTERY LEVEL, The University of Mississippi Medical Center's Office of Diversity and Inclusion | 01/2022 - Present |
| Certification, UMMC Diversity and Inclusion Champion & Professional development Certificate Program 2021, The University of Mississippi Medical Center's Office of Diversity and Inclusion | 06/2021 - Present |
Current Positions
| Assistant Professor, School of Medicine, Department of Radiation / Oncology | 07/2023 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Instructor, The University of Mississippi Medical Center, School of Medicine, Department of Radiation / Oncology | 07/2022 - 07/2023 |
Publications
Journal Article | |
| Jones ML, Vijayakumar S, Nittala MR, Bruson CD An Interdisciplinary Perspective on Improving Cancer Care in the State of Mississippi as an Example of Cancer Care Improvements in the Global South Cureus. 2025;17: e76865 | 2025 |
| Velu U, Singh A, Nittala MR, Yang J, Vijayakumar S, Cherukuri C, Vance GR, Salvemini JD, Hathaway BF, Grady C, Roux JA, Lewis S. Precision Population Cancer Medicine in Brain Tumors: A Potential Roadmap to Improve Outcomes and Strategize the Steps to Bring Interdisciplinary Interventions. Cureus 2024; 16: e71305. | 2024 |
| Singh A, Velu U, Lewis S, Nittala MR, Yang J, Vijayakumar S. India’s Potential as a Leader in Cancer Care Progress in the Future: A Synthetic Interdisciplinary Perspective. Cureus 2024; 16: e70892. | 2024 |
| Wilfried BA, Rachel TT, MirkhaghaniHaghighi, Nittala MR, Mourad W, Mobit P. Case Report: A Rare Case of an Atypical Lipomatous Tumor. Medi Clin Case Rep J 2024; 2: 334-336. | 2024 |
| Mobit P, Yang C, Nittala MR, He Rui, Ahmed HZ, Schultz G, Lin A, Vijayakumar S. Eye Plaque Brachytherapy for Choroidal Malignant Melanoma: A Case Report on the Use of Innovative Technology to Expand Access, Improve Practice, and Enhance Outcomes. Cureus 16(2): e54572. | 2024 |
| Nittala MR, Yang J, Velazquez AE, Salvemini JD, Vance GR, Grady CC, Hathaway B, Roux JA, Vijayakumar S. Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical Cancer. Cureus. 2024; 16:e53733 | 2024 |
| Yang J, Nittala MR, Velazquez AE, Buddala V, Vijayakumar S An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series Cureus.2023; 15:e37889 | 2023 |
| Vijayakumar S, Nittala MR, Buddala V, Mobit P, Duggar WN, Yang CC, Lirette ST, Mundra E, Ahmed HZ, Berry SM, Craft BS, Woods WC, Otts J, Rahimi A, Dobbs T. Real World and Public Health Perspectives of Intraoperative Radiotherapy in Early-Stage Breast Cancer: A Multidisciplinary Analysis Beyond the Statistical Facts Cureus. 2023; 15:e36432 | 2023 |
| Vijayakumar S, Nittala MR, Duggar WN, King M, Lirette ST, Yang CC, Mundra E, Woods WC, Otts J, Doherty M, Panter P, Howard C, Ridgway M, Allbright R The Influence of Patient and System Factors on the Radiotherapy Treatment Time in the Treatment of Non-metastatic Cervical Cancer Patients in a Rural and Resource-Lean State's Safety-Net Hospital: Benefits of Strategic Planning Cureus. 2023; 15:e35954 | 2023 |
| Ahmed HZ, Nittala MR, Kosalram N, Crosswhite B, Lee AP, Frazier TC, Milner CP, Vijayakumar S. Patients and Families’ Participation in Multidisciplinary Tumor Conferences Improves Patient and Family-Focused Cancer Care: Lessons Learned from a Debate on the Role of Radiation Therapy in Primary Mediastinal Non-Hodgkin Lymphoma. Cureus.2023; 15(2): e34693 | 2023 |
| Vijayakumar S, Lancaster FB, Nittala MR, Duggar WN. The Emerging Boon of Information and Communication Technology in Multidisciplinary Cancer Care: A Force Multiplier with a Human Touch. Cureus. 2023; 15(1): e33665 | 2023 |
| Duggar WN, Weatherall LM, Nittala MR, Vengaloor Thomas T, Mundra EK, Otts J, Woods WC, Yang CC, Vijayakumar S. Strategic Reduction of Package Time in Head and Neck Cancer Advances in Radiation Oncology. AdvancesRadOnc. 2022; 8(1): 101117 | 2023 |
| Vijayakumar S, Yang J, Nittala MR, Velazquez AE, Huddleston BL, Rugnath NA, Adari N, Yajurvedi AK, Komanduri A, Yang CC, Duggar WN, Berlin WP, Duszak R, Vijayakumar V. Changing Role of PET/CT in Cancer Care with a Focus on Radiotherapy. Cureus. 2022; 14 (12): e32840 | 2022 |
| Vijayakumar S, King ML, Nittala MR, Duhe RJ. Do we need a New Approach to Cancer Biology Education for Radiation Oncology Residents. Cureus. 2021; 13(12): e20662 | 2021 |
| Farkas AB, Green ED, Thaggard AL, Vijayakumar V, Henegan JC, Lirette ST, Nittala MR, Vijayakumar S. Initial Institutional Experience with 18-F Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer. SMJ, 2021; 114(11): 703-707 | 2021 |
| Vengaloor Thomas T, Reddy KK, Gandhi Shivanthidevi, Nittala MR, Abraham A, Robinson W, Ridgway M, Packianathan S, Vijayakumar S. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Analysis Using a Single-Institution Patient Cohort. Cureus. 2021; 13(11): e19289 | 2021 |
| Nittala MR, Duggar WN, Mundra E, Packianathan S, Smith ML, Woods WC, Otts J, Bhandari R, Allbright R, De Delva PE, Moremen JR, Yang CC, Vijayakumar S. Single Institution Experience of Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer: Comparison of Two Dose Regimes and a Perspective on Ideal Dose Regimens. Cureus. 2021; 13(10): e18862 | 2021 |
| Nittala MR, Mundra EK, Packianathan S, Mehta D, Smith ML, Woods WC, McKinney SA, Craft BS, Vijayakumar S. The Will Rogers phenomenon, breast cancer and race. BMC Cancer. 2021; 21:554 | 2021 |
| Nittala MR, Kanakamedala MR, Mundra E, Vengaloor Thomas T, Bhanat E, Woods WC, Vijayakumar S. Factors Affecting Outcomes in Patients with Stage III & IV Squamous Cell Carcinoma of Oropharynx. Cureus. 2021; 13(3): e13674 | 2021 |
| Nittala MR, Kanakamedala MR, Mundra E, Woods WC, Smith ML, Hamilton RD, Jefferson GD, Jackson L, Packianathan S, Vijayakumar S. Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better with Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma. Cureus. 2021; 13(1): e13022 | 2021 |
| King ML, Nittala MR, Gordy XZ, Roberts P, Lirette S, Vengaloor Thomas T, Gordy DP, Albert AA, Vijayakumar V, Vijayakumar V. Prostate Cancer Screening Recommendations for the General and Special Populations in the Western Nations. European Medical Journal. 2020; 10:33590 | 2020 |
| Vengaloor Thomas T, Krishna K, Ahmed HZ, Mundra E, Abraham A, Bhanat E, Nittala MR, Packianathan S, Vijayakumar S. A 25-year Experience at an Academic Medical Center in the United States: Are There Racial Disparities in the Prognosis of Patients Diagnosed With Hypopharyngeal Carcinoma? Cureus. 2020; 12(11): e11306 | 2020 |
| Vengaloor Thomas T, Nittala MR, Bhanat E, Albert AA, Vijayakumar S. Management of Advanced-stage Hypopharyngeal Carcinoma: 25-Year Experience from a Tertiary Care Medical Center. Cureus. 2020; 12(1): e6679 | 2020 |
| King ML, Joseph S, Albert A, Thomas TV, Nittala MR, Woods WC, Vijayakumar S, Packianathan S. Use of Amifostine for Cytoprotection during Radiation Therapy: A Review. Oncology. 2020; 98:61-80 | 2019 |
| King ML, Vengaloor Thomas T, Albert AA, Joseph S, Ramachandran Nair L, Lam JT, Woods WC, Nittala MR, Vijayakumar S. A Case of Transformation of Primary Cutaneous Follicle Center Lymphoma to Diffuse Large B-Cell Lymphoma Involving the Parotid Gland and Cervical Lymph Nodes. Am. J.Case Rep.2019; 20, 1273–1278 | 2019 |
| Albert A, Mangana S, Nittala MR, Thomas TV, Weatherall L, Vijayakumar S. The impact of a postmastectomy chest wall scar boost on local recurrence- free survival in high-risk patients. Clinical Breast Cancer. 2019; 19 (5): 363-369. | 2019 |
Abstracts | |
| Yang J, Nittala MR, Mishoe RV, Lam M, Lamar L, Vijayakumar V Healthcare Disparities of Radium-223 Treatment in Metastatic Castrate-Resistant Prostate Cancer Care in Mississippi Radiological Society of North America Annual Meeting 2024 | 2024 |
| Mishoe RV, Yang J, Nittala MR, Salvemini J, Lam M, Grady C, Vijayakumar V. Healthcare Disparities of Radium-223 Treatment in Metastatic Castrate-Resistant Prostate Cancer Care in Mississippi. Rural Medicine Education Symposium: 3rd Annual Meeting | 2024 |
| Duggar WN, Weatherall LM, Nittala MR, Thomas TV, Mundra EK, Otts J, Woods WC, Yang CC, Vijayakumar S. Strategic Reduction of Package Time in Head and Neck Cancer. Intl J Rad Onc Bio Phys.2022; 114 (3):e110-e111 | 2022 |
| Duggar WN, Weatherall LM, Nittala MR, Vengaloor Thomas T, Mundra EK, Otts J, Woods WC, Yang CC, Vijayakumar S. Strategic Reduction of Package Time in Head and Neck Cancer. AdvancesRadOnc. 2022; 8(1): 101117 | 2022 |
| Duggar WN, Weatherall LM, Nittala MR, Thomas TV, Mundra EK, Otts J, Woods WC, Yang CC, Vijayakumar S. Implementation of Accountability Strategy to Improve Package Time. | 2022 |
| Nittala MR, Mundra EK, Packianathan S, Smith ML, Woods WC, Allbright R, Vijayakumar S. Single Institution Experience of Stereotactic Body Radiation therapy (SBRT) in Lung Cancer. | 2021 |
| Nittala MR, Mundra EK, Packianathan S, Shultz GL, Woods WC, Smith ML, Craft BS, Vijayakumar S. Ductal carcinoma in situ (DCIS) of the breast: Impact of age, grade, and receptor status on survival. | 2021 |
| Nittala MR, Packianathan S, Mundra EK, King ML, Gandhi S, Allbright RM, Smith ML, Woods WC, Thomas TV, Ridway M, Vijayakumar S. Survival and Local Control among African-Americans and Caucasians following Treatment of Cervix Cancer in a University Medical Center. International Journal of Radiation Oncology*Biology*Physics. 2020; 108 (3): e496 | 2020 |
| Nittala MR, Mundra EK, King ML, Albert A, Woods WC, Smith ML, Hamilton RD, Jackson L, Jefferson G, Packianathan S, Manucha V, Vijayakumar S Impact of race on outcomes in oropharyngeal squamous-cell carcinoma patients with known HPV/p16 status. Cancer Epidemiol Biomarkers Prev 2020; 29(12): Abstract nr PO-104 | 2020 |
| Nittala MR, Packianathan S, Mundra EK, King ML, Gandhi S, Allbright RM, Smith ML, Woods WC, Thomas TV, Ridgway R, Vijayakumar S. Improved Clinical Outcomes with Shorter Intervals between Concurrent Chemoradiation and Brachytherapy in FIGO IB2- IVA Cervical Cancer Patients among a predominantly African-American Population. Cancer Epidemiol Biomarkers Prev 2020; 29(12): Abstract nr PO-230 | 2020 |
| Nittala MR, Mundra EK, Albert A, Woods WC, Smith ML, Hamilton RD, Jackson L, Jefferson G, Packianathan S, Bhanat E, Manucha V, Vijayakumar S. Univariate and Multivariate prognostic factors for overall survival among oropharyngeal cancer patients with known HPV/p16 status. Cancer Epidemiol Biomarkers Prev 2020; 29(12): Abstract nr PO-232 | 2020 |
| Nittala MR, Mundra EK, Smith ML, Woods WC, Hamilton R, Jefferson G, Jackson L, Vijayakumar S Improved Clinical Outcomes with Shorter Intervals between Surgery and Postoperative Radiotherapy in T4 Laryngeal Cancers. International Journal of Radiation Oncology*Biology*Physics. 2020; 108(2): e40. Abstract nr PO44 | 2020 |
| Nittala MR, Mundra EK, Smith ML, Woods WC, Hamilton R, Jefferson G, Jackson L, Packianathan S, Mehta D, Allbright R, Vijayakumar S. Impact of Race on Outcomes in T1 Glottic Cancer patients after Radiation Therapy (RT). International Journal of Radiation Oncology*Biology*Physics. 2020; 108(2): e48 | 2020 |
| Vengaloor Thomas T, Nittala MR, Bhanat E, Kuruvilla TP, Vijayakumar S. Advanced - Stage Hypo pharyngeal Carcinoma management: A Retrospective Review of 25-years of experience. International Journal of Radiation Oncology*Biology*Physics. 2020; 108(2): e49. Abstract nr PO45 | 2020 |
| Joseph S, Nittala MR, Roberts P, King M, Ahmed H, Albert A, Thomas T, Allbright R, Packianathan S, Mundra EK, Vijayakumar S. Prospective Planning of Radiation Treatment at New Patient Conference during the COVID-19 Pandemic: The University of Mississippi Medical Center Experience. Clin Cancer Res 2020; 26(18l): Abstract nr PO-034 | 2020 |
| Nittala MR, Bhanat E, Kanakamedala M, Vijayakumar S. Factors affecting outcomes in patients with Squamous Cell Carcinoma of Oropharynx. Clin Cancer Res 2020; 26(12): Abstract nr B21 | 2020 |
| Vengaloor Thomas T, Nittala MR, Mehta D, Kanakamedala M, Abraham A, Watherall L, Bhanat E, Albert AA, Vijayakumar S. Advanced Stage Hypopharyngeal carcinoma management: 25-year experience from a tertiary care medical center. Clin Cancer Res 2020; 26(12): Abstract nr B20 | 2020 |
| Nittala MR, Kanakamedala MR, Mundra E, Vijayakumar S. QALYs and DALYs are better with concurrent chemoRT than induction chemo followed by chemoRT in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2020; 29(6): Abstract nr C016 | 2020 |
| Nittala MR, Mundra EK, Packianathan S, Mehta D, Woods WC, Mckinney S, Craft BS, Vijayakumar S. The Will Rogers Phenomenon in breast cancer: The AJCC 8th Ed. and the importance of caution in the interpretation of outcomes differences for overall population and race-specific cohorts. Cancer Epidemiol Biomarkers Prev 2020; 29(6): Abstract nr B126 | 2020 |
| Vengaloor Thomas T, Nittala MR, Kuruvilla TP, Abraham A, Bhanat E, Packianathan S, Kanakamedala M, Vijayakumar S. Is there a racial disparity in the prognosis of hypopharyngeal carcinoma? 25-year experience from a tertiary care medical center in the United States. Cancer Epidemiol Biomarkers Prev 2020; 29(6): Abstract nr D127 | 2020 |
| Nittala MR, Mundra EK, Packianathan S, Mehta D, Smith ML, Woods WC, McKinney S, Craft BS, Vijayakumar S. Triple Negative Breast Cancer Patients treated with Radiation Therapy: Improvement in Survival and Local Control with Adjuvant Chemotherapy compared to Neoadjuvant Chemotherapy. Cancer Res 2020; 80(16): Abstract nr 6177 | 2020 |
| Vengaloor Thomas T, Gandhi S, Nittala MR, Albert AA, Abraham A, Packianathan S, Vijayakumar S. Stage migration in cervical cancer using the FIGO 2018 staging system: a retrospective survival analysis using a single institution patient cohort. Is there a Will Rogers phenomenon? International Journal of Radiation Oncology*Biology*Physics. 2019; 105(1): e338. Abstract nr 2776 | 2019 |
Dissertation | |
| Nittala MR. Outcomes following Treatment for Head and Neck Cancer. | 2019 |
Presentations
| Poster Presentation, Healthcare Disparities of Radium-223 Treatment in Metastatic Castrate-Resistant Prostate Cancer Care in Mississippi, Radiological Society of North America Annual Meeting, Chicago, IL, USA | 12/2024 |
| Poster Presentation, A Retrospective Analysis of Socioeconomic Factors on the Overall Survival of Patients with Brain Metastases of less than 2 cm after undergoing Gamma Knife Surgery, MSRP, Jackson, MS, USA | 07/2024 |
| Poster Presentation, Timing Matters: Impact of Treatment Duration on Post-Op Cervical Cancer Patients' Survival- A Retrospective Analysis at The University of Mississippi Medical Center, UMMC OBGYN Research, Jackson, MS, USA | 05/2024 |
| Poster Presentation, Social Determinants of Health Associated with Cervical Cancer Survival: A Retrospective Study, UMMC OBGYN Research, Jackson, MS | 05/2024 |
| Poster Presentation, Evolving Role of Artificial Intelligence and Radiomics in Precision Population Medicine for Cancer Care: Brain Tumors, American College of Radiology National Meeting, Washington, DC, USA | 04/2024 |
| Poster Presentation, Evolving Role of Artificial Intelligence and Radiomics in Precision Population Medicine for Cancer Care: Head and Neck Cancer, American College of Radiology National Meeting, Washington, DC, USA | 04/2024 |
| Poster Presentation, Evolving Role of Artificial Intelligence and Radiomics in Precision Population Medicine for Cancer Care: Cervical Cancer, American College of Radiology National Meeting, Washington, DC, USA | 04/2024 |
| Poster Presentation, Evolving Role of Artificial Intelligence and Radiomics in Precision Population Medicine for Cancer Care: Breast Cancer, American College of Radiology National Meeting, Washington, DC, USA | 04/2024 |
| Poster Presentation, Evolving Role of Artificial Intelligence and Radiomics in Precision Population Medicine for Cancer Care: Defining the Boundaries of Precision Population Medicine, American College of Radiology National Meeting, Washington, DC, USA | 04/2024 |
| Poster Presentation, Healthcare Disparities of Radium-223 Treatment in Metastatic Castrate-Resistant Prostate Cancer Care in Mississippi., Rural Medicine Education Symposium: 3rd Annual Meeting, Jackson, MS, USA | 02/2024 |
| National and International Invited Seminars/Lectures, Radio biotherapy and Radio biomedicine- The Future of Radiotherapy Beyond Cancer: A Way to Leapfrog in Improving Cancer Care in India, American Association of Physicians of Indian Origin (AAPI), 17th Annual Global Health Care Summit, New Delhi, India | 01/2024 |
| National and International Invited Seminars/Lectures, Precision Population Medicine in Cancer Care: Leveraging India's New Prowess in Digital, IT, Infrastructure Improvements to Become World Leader in Cancer Care, American Association of Physicians of Indian Origin (AAPI), 17th Annual Global Health Care Summit, Manipal, India | 01/2024 |
| Poster Presentation, Strategic Reduction of Package Time in Head and Neck Cancer., American Society of Radiation Oncology, San Antonio, Texas, USA | 10/2022 |
| Professional Interactive ePoster Discussion, Implementation of Accountability Strategy to Improve Package Time, American Association of Physicists in Medicine, Washington, DC, USA | 07/2022 |
| Poster Presentation, Single Institution Experience of Stereotactic Body Radiation therapy (SBRT) in Lung Cancer., American Radium Society, Lahaina, HI, USA | 10/2021 |
| Poster Presentation, Ductal carcinoma in situ (DCIS) of the breast: Impact of age, grade, and receptor status on survival., American Radium Society, Lahaina, HI, USA | 10/2021 |
| Invited Symposia, Prospective Planning of Radiation Treatment during COVID-19 Pandemic: The University of Mississippi Medical Center Experience., RE bounce Global Medical Conference | 05/2021 |
| Invited Symposia, COVID-19 and Emotional Wellbeing, Group on Women in Medicine and Science, UMMC, Jackson, MS, USA | 11/2020 |
| Poster Presentation, Advanced - Stage Hypo pharyngeal Carcinoma management: A Retrospective Review of 25-years of experience., American, Miami Beach, FL, USA | 10/2020 |
| Poster Presentation, Survival and Local Control among African-Americans and Caucasians following Treatment of Cervix Cancer in a University Medical Center., American Society for Radiation Oncology, Chicago, IL, USA | 10/2020 |
| Poster Presentation, QALYs and DALYs are better with concurrent chemoRT than induction chemo followed by chemoRT in nasopharyngeal carcinoma., American Association for Cancer Research, San Francisco, CA, USA | 10/2020 |
| Poster Presentation, Is there a racial disparity in the prognosis of hypopharyngeal carcinoma? 25-year experience from a tertiary care medical center in the United States., American Association for Cancer Research, San Francisco, CA, USA | 10/2020 |
| Poster Presentation, The Will Rogers Phenomenon in breast cancer: The AJCC 8th Ed. and the importance of caution in the interpretation of outcomes differences for overall population and race-specific cohorts., American Association for Cancer Research, San Francisco, CA, USA | 10/2020 |
| Poster Presentation, Improved Clinical Outcomes with Shorter Intervals between Surgery and Postoperative Radiotherapy in T4 Laryngeal Cancers., American Radium Society, Boston, MA, USA | 10/2020 |
| Poster Presentation, Impact of Race on Outcomes in T1 Glottic Cancer patients after Radiation Therapy (RT)., American Radium Society, Boston, MA, USA | 10/2020 |
| Poster Presentation, Impact of race on outcomes in oropharyngeal squamous-cell carcinoma patients with known HPV/p16 status., American Association for Cancer Research, Philadelphia, PA, USA | 10/2020 |
| Poster Presentation, Improved Clinical Outcomes with Shorter Intervals between Concurrent Chemoradiation and Brachytherapy in FIGO IB2- IVA Cervical Cancer Patients among a predominantly African-American Population., American Association for Cancer Research, Philadelphia, PA, USA | 10/2020 |
| Poster Presentation, Univariate and Multivariate prognostic factors for overall survival among oropharyngeal cancer patients with known HPV/p16 status., American Association for Cancer Research, Philadelphia, PA, USA | 10/2020 |
| Poster Presentation, Prospective Planning of Radiation Treatment at New Patient Conference during the COVID-19 Pandemic: The University of Mississippi Medical Center Experience., American Association for Cancer Research, Philadelphia, PA, USA | 07/2020 |
| Poster Presentation, Triple Negative Breast Cancer Patients treated with Radiation Therapy: Improvement in Survival and Local Control with Adjuvant Chemotherapy compared to Neoadjuvant Chemotherapy., American Association for Cancer Research, Philadelphia, PA, USA | 06/2020 |
| Poster Presentation, Stage migration in cervical cancer using the FIGO 2018 staging system: a retrospective survival analysis using a single institution patient cohort. Is there a Will Rogers phenomenon?, American Society for Radiation Oncology, Chicago, Illinois, USA | 09/2019 |
| Poster Presentation, Factors affecting outcomes in patients with Squamous Cell Carcinoma of Oropharynx., American Association for Cancer Research, Austin, TX, USA | 04/2019 |
| Poster Presentation, Advanced Stage Hypopharyngeal carcinoma management: 25-year experience from a tertiary care medical center., American Association for Cancer Research, Austin, TX, USA | 04/2019 |
Honors, Awards, and Recognition
| Community Engaged Research Summer Institute, The Mississippi Center for Clinical and Translational Research | 2024 |
| The Pillars Beacon Award Honorable Mention 2024, The University of Mississippi Medical Center | 2024 |
| The Postdoctoral Fellow Award 2022, The University of Mississippi Medical Center | 2022 |
| The Pillars Excellence Award Nominated 2022, The University of Mississippi Medical Center | 2022 |
| Diversity and Inclusion Champion Mastery Level 2021, The University of Mississippi Medical Center | 2021 |
| Ranked First in American Radium Society leaderboard 2021, American Radium Society | 2021 |
| GWIMS Trainee Recognition Award 2021, The University of Mississippi Medical Center | 2021 |
| Guest of Honor Award 2021, RE bounce Global Medical Conference | 2021 |
| Department of Radiation Oncology Research Recognition Award 2021, The University of Mississippi Medical Center | 2021 |
| Fellow Royal Society for Public Health (FRSPH), Royal Society for Public Health | 2021 |
| Ranked Second in ASTRO leaderboard 2020, American Society for Radiation Oncology | 2020 |
| Top-rated scientific abstract - 62nd ASTRO annual meeting 2020, American Society for Radiation Oncology | 2020 |
| AACR Scholar in training Award 2020, American Association for Cancer Research | 2019 |
| AACR Scholar in training Award 2019, American Association for Cancer Research | 2019 |
| Coach Brent’s US Army Fitness Award, Jackson State University | 2018 |
| The Top Research Award 2008, American Chemical Society | 2008 |
| National Honor Society Scholarship | 2005 |
| Award of Excellence in Medical Biochemistry | 2003 |
Professional Membership and Service
| UMMC Group on Women in Medicine and Science (GWIMS), Officer-President | 2024 - Present |
| UMMC Group on Women in Medicine and Science (GWIMS), Officer, Vice President | 2023 - 2024 |
| UMMC Group on Women in Medicine and Science (GWIMS), Officer, Secretary | 2022 - 2023 |
| UMMC SGSHS Office of Postdoctoral Studies (2021-2022), Advisory Committee Member | 2021 - 2022 |
| American College of Healthcare Executives (ACHE), Member | 2021 - 2022 |
| UMMC Group on Women in Medicine and Science (GWIMS), Trainee Representative | 2021 - 2022 |
| Royal Society for Public Health (RSPH), Fellow | 2021 - Present |
| National Postdoctoral Association (NPA), Member | 2021 - Present |
| Group on Women in Medicine and Science (GWIMS), Member | 2020 - Present |
| American Society for Radiation Oncology (ASTRO), Member | 2020 - Present |
| American Society of Clinical Oncology (ASCO), Associate Member | 2020 - Present |
| American Association for Cancer Research (AACR), Associate Member | 2019 - Present |
| Women in Cancer Research (WICR), Member | 2019 - Present |
| Minorities in Cancer Research (MICR), Member | 2019 - Present |
| Cancer Immunology Working Group (CIMM), Member | 2019 - Present |
| Pediatric Cancer Working Group (PCWG), Member | 2019 - Present |
| Molecular Epidemiology Working Group (MEG), Member | 2019 - Present |
Committee Service
| UM - FACULTY SENATE, Faculty Senator - SOM | 2025 - Present |
| Group on Women in Medicine and Science (GWIMS), Executive Board- President | 2024 - Present |
| RadOnc Research Strategic Development Team, Chair | 2023 - Present |
| Group on Women in Medicine and Science (GWIMS), Executive Board- President Elect | 2023 - 2024 |
| RadOnc Wellness Council | 2023 - 2024 |
| Group on Women in Medicine and Science (GWIMS), Executive Board- Secretary | 2022 - 2023 |
| Department of Radiation Oncology Research Council, Chair | 2022 - Present |
| UMMC SGSHS Office of Postdoctoral Studies, Advisory Committee Member | 2021 - 2022 |
| American Association of Physicians of Indian Origin (AAPI)- Mississippi, Co-Chair Membership | 2021 - Present |
| Group on Women in Medicine and Science (GWIMS), Executive Board- Trainee Representative | 2021 - 2022 |
| Jackson State University Indian Student Association, Steering Comittee Member | 2006 - 2009 |
Community Service
| Image Bearers-Special Needs Kids at Colonial Heights Baptist Church, Staff | 08/2021 - Present |
| Indian Association of Mississippi (IAM), Executive Board Member | 2015 - 12/2019 |
Other Service
| UMMC MSRP, Mentor | 11/2023 - Present |
| Cureus, Associate Editor | 08/2023 - Present |
| BMC Cancer, Reviewer | 04/2023 - Present |
| Cureus, Reviewer | 01/2022 - Present |
| Therapeutic Advances in Medical Oncology, Reviewer | 10/2021 - Present |
| Journal of International Medical Research, Reviewer | 08/2021 - Present |
| American Journal of Case Reports, Reviewer | 11/2019 - Present |
Directed Student Learning
| Research Advisor, Advised: Aaron Kwag | 2024 - Present |
| Research Advisor, Advised: Michael Whelan | 2024 - Present |
| Research Advisor, Advised: Grace Howell | 2024 - Present |
| Research Advisor, Advised: Nickhil A Rugnath | 2024 - Present |
| Research Advisor, Advised: Tyler Welch | 2024 - Present |
| Research Advisor, Advised: Advait Praveen | 2024 - Present |
| Research Advisor, Advised: C Flannery Voges-haupt | 2024 - Present |
| Research Advisor, Advised: Pooja Keriwala | 2024 - Present |
| Research Advisor, Advised: Adam Davis | 2024 - Present |
| Supervised Research, 1. Social Determinants of Health Associated with Cervical Cancer Survival: A Retrospective Study. 2. Radiation Therapy: Is two better than one? A comparative study Advised: Kamryn Davis | 2024 - Present |
| Supervised Research, Social Determinants of Health Associated with Cervical Cancer Survival: A Retrospective Study Advised: Jessica Jasper | 2024 - Present |
| Supervised Research, Social Determinants of Health Associated with Cervical Cancer Survival: A Retrospective Study Advised: Hannah Talbot | 2024 - Present |
| Research Advisor, Advised: Nelson Howell | 2024 - Present |
| Supervised Research, Timing Matters: Impact of Treatment Duration on Post-Op Cervical Cancer Patients' Survival-A Retrospective Analysis at the University of Mississippi Medical Center Advised: Anhthu Truong | 2024 - Present |
| Supervised Research, Timing Matters: Impact of Treatment Duration on Post-Op Cervical Cancer Patients' Survival-A Retrospective Analysis at the University of Mississippi Medical Center Advised: Megha Patel | 2024 - Present |
| Supervised Research, Among cervical (FIGO Stage IB2 IVA) cancer treated at a state academic medical center: Impact of race on the survival and local control outcomes. Advised: Hien Nguyen | 2023 - Present |
| Supervised Research, 1. Racial disparities among cervical cancer patients treated at a state academic medical center. 2. Breaking the skin: Contextualizing the history of surgical melanoma treatment and racial disparities in survival and prevention. Advised: Faith Brown | 2023 - Present |
| Supervised Research, A single institutional retrospective study on the role of Gamma Knife surgery in brain metastases intact lesions less than 2 cm: Impact of race on the survival outcomes. Advised: Karen Wong | 2023 - Present |
| Supervised Research, 1. Racial disparities among brain metastases patients treated at a state academic medical center. 2. Cutting edge is not for everyone: The rise of stereotactic radiosurgery for brain metastasis and coinciding sociodemographic disparity. Advised: Alexa Lee | 2023 - Present |
| Research Advisor, Evolving role of artificial intelligence and radiomics in precision population medicine for cancer care: Defining the boundaries of precision population medicine. Advised: Chanukya Cherukuri | 2023 - Present |
| Supervised Research, 1. Precision population cancer medicine in cancer of the uterine cervix: A potential roadmap to eradicate cervical cancer. 2. Evolving role of artificial intelligence and radiomics in precision population medicine for cancer care: Breast cancer. Advised: Jeffrey Roux | 2023 - Present |
| Supervised Research, 1. Precision population cancer medicine in cancer of the uterine cervix: A potential roadmap to eradicate cervical cancer. 2. Evolving role of artificial intelligence and radiomics in precision population medicine for cancer care: Head and Neck cancer. Advised: Bradley Hathaway | 2023 - Present |
| Supervised Research, The emerging boon of information and communication technology in multidisciplinary cancer care: A force multiplier with a human touch. Advised: Frances Lancaster | 2022 - 2023 |
| Supervised Research, 1. To elucidate the interplay between treatment outcomes of Ra-223 in patients with mCRPC when stratified among races and SODH. 2. Changing role of PET/CT in cancer care with a focus on radiotherapy. 3. An overview of the use of precision population medicine in cancer care: First of a series. 4. Precision population cancer medicine in cancer of the uterine cervix: A potential roadmap to eradicate cervical cancer. Advised: Johnny Yang | 2022 - Present |
| Supervised Research, 1. Changing role of PET/CT in cancer care with a focus on radiotherapy. 2. An overview of the use of precision population medicine in cancer care: First of a series. 3. Precision population cancer medicine in cancer of the uterine cervix: A potential roadmap to eradicate cervical cancer. Advised: Alexander Velazquez | 2022 - Present |
| Supervised Research, Patients and families’ participation in multidisciplinary tumor conferences improves patient and family-focused cancer care: Lessons learned from a debate on the role of radiation therapy in primary mediastinal non-Hodgkin lymphoma. Advised: Betsy Crosswhite | 2022 - 2023 |
| Supervised Research, Patients and families’ participation in multidisciplinary tumor conferences improves patient and family-focused cancer care: Lessons learned from a debate on the role of radiation therapy in primary mediastinal non-Hodgkin lymphoma. Advised: Nivedha Kosalram | 2022 - 2023 |
| Supervised Research, Precision population cancer medicine in cancer of the uterine cervix: A potential roadmap to eradicate cervical cancer. Advised: Camille Gardy | 2022 - Present |
| Supervised Research, 1. Precision population cancer medicine in cancer of the uterine cervix: A potential roadmap to eradicate cervical cancer. 2. Evolving role of artificial intelligence and radiomics in precision population medicine for cancer care: Brain tumors. Advised: Gregory Vance | 2022 - Present |
| Supervised Research, 1. Precision population cancer medicine in cancer of the uterine cervix: A potential roadmap to eradicate cervical cancer. 2. Evolving role of artificial intelligence and radiomics in precision population medicine for cancer care: Cervical cancer. Advised: John Salvemani | 2022 - Present |
| Supervised Research, 1. Real world and public health perspectives of intraoperative radiotherapy in early-stage breast cancer: A multidisciplinary analysis beyond the statistical facts. 2. Changing role of PET/CT in cancer care with a focus on radiotherapy. Advised: Vedanth Buddala | 2021 - 2023 |
Residency Training
| Radiation Oncology, Research Advisor | 2019 - Present |